1.
Bardazzi F, Filippi F, Mussi M, Lasagni C, Bigi L, Odorici G, et al. Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab. Dermatol Pract Concept [Internet]. 2024 Jul. 31 [cited 2025 Jan. 22];14(3):e2024171. Available from: https://www.dpcj.org/index.php/dpc/article/view/4097